The following nine stocks are among the best growth stocks to buy for the next 10 years, based on their wide moat, history of ...

Carvana gave a generally upbeat outlook for used car sales late Wednesday after easily beating earnings and revenue estimates ...

From Trump tariffs to AI overconfidence, investors are ignoring a lot of worries right now. That could be a dangerous sign ...

Wall Street is sliding toward losses in premarket trading after Walmart, the nation’s biggest retailer and a bellwether for ...

Buying $100 In EQIX: If an investor had bought $100 of EQIX stock 20 years ago, it would be worth $2,144.51 today based on a ...

The S&P 500 (SNPINDEX: ^GSPC) has advanced 71% since entering the current bull market in October 2022. Factors contributing ...

Intel shares rallied more than 10% on Tuesday on a report that deals from Broadcom and Taiwan Semiconductor Manufacturing ...

The Nifty index opened flat, and witnessed selling pressure in the first half, but saw a sharp recovery in the second half, ...

Brett Arends is an award-winning financial writer with many years experience writing about markets, economics and personal finance. He has received an individual award from the Society of American ...

Don’t look to hedge funds to rescue your portfolio from the mediocre returns that stocks and bonds are likely to produce over ...

A long bear candle was formed on the weekly chart, which indicates a reversal on the downside after the two weeks of upside ...

Company reported positive Phase 2b QUALITY study topline results for enobosarm + semaglutide (Wegovy®) with study meeting prespecified primary endpoint of preservation of lean mass as well as greater ...